Could a web tool replace some Parkinson's clinic visits?

NCT ID NCT05164783

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 25, 2026 · Last updated Sep 25, 2026

Summary

Researchers are studying whether a web-based monitoring tool called SanaCoach Parkinson can provide care for people with Parkinson's disease that is as good as usual clinic visits, while reducing healthcare use and costs. Participants complete regular online questionnaires about their symptoms, and doctors can adjust treatment based on the results. The study follows patients for two years to see how the tool affects quality of care, quality of life, and costs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SanaCoach Parkinson, a web-based monitoring tool that tracks Parkinson's symptoms through questionnaires
What this could lead to
If it works, this could give people with Parkinson's a way to manage their care from home, with fewer clinic visits and earlier detection of worsening symptoms.
What could go wrong
This is an implementation study, not a randomized trial, so results may not prove the tool works better than standard care. Some patients may struggle with the technology or prefer in-person visits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

258 people

The number who actually took part.

Started

Nov 2021

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease * Disease duration ≥ 3 months. * Able to complete the questionnaires and use the Sanacoach Parkinson, independently or with the help of an informal caregiver. Exclusion Criteria: * Not able to understand and/or sign the informed consent. * No access to the internet via computer, tablet or smartphone. * Participating in other trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Elkerliek Hospital

    Helmond, Netherlands

  • Meander Medical Center

    Amersfoort, Netherlands

  • Onze Lieve Vrouwe Hospital

    Amsterdam, Netherlands

  • Rode Kruis Hospital

    Beverwijk, Netherlands

  • Zuyderland Medical Center

    Geleen, Netherlands

  • Zuyderland Medical Center

    Heerlen, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.